The Translational Science Interagency Fellowship (TSIF) program is mutually supported by NCATS and the U.S. Food and Drug Administration (FDA) and means to give training in both translational science and administrative science. The shared objective of NCATS and the FDA is to bring protected and effective medications, regimens, and gadgets from the bench to the bedside as fast and effectively as could be expected. Keeping that in mind, the selected fellows will be trained in preclinical translational science, technology advancement, and administrative research and review. By joining training in translational science and research-related executive survey, this program will empower fellows to incorporate familiarity with administrative requirements into the beginning phases of clinical product improvement, further developing efficiencies in both the turn of events and audit measures. Fellows in this program will foster abilities of significant worth to future professions in the scholarly community, the medicine industry, and government.
As for eligibility, the candidate applying for this fellowship must have a Ph.D., M.D., or another doctoral degree in a related discipline by their arrangement date and have finished close to two years of earlier postdoctoral training. The candidate must also be a U.S. resident or permanent resident also, have resided in the United States for three of the five years. This fellowship is a three-year program. Early September 2022 is the favored beginning date. Fellows will spend the initial 12–year and a half of the company at the FDA and the rest of the cooperation at NCATS. The deadline to apply for the following fellowship is December 15, 2021.
The National Center for Advancing Translational Sciences (NCATS) — one of 27 Institutes and Centers at the National Institutes of Health (NIH) — was set up to change the translational interaction with the goal that new medicines and solutions for infection can be conveyed to patients quickly and effectively.
Table of Contents
Below we have a brief description of the following scholarship:
|Number of Awards||N/A|
|Contest Deadline||December 15, 2021|
|Application Fees||Not required|
|Requirements||CV, letters of reference, transcript, personal statement|
Who is Eligible?
The eligibility criteria for the following scholarship is as follows:
- Have a Ph.D., M.D., or another doctoral degree in a related discipline by their appointment date
- Have completed no more than two years of prior postdoctoral training
- Be a U.S. citizen or permanent resident and have resided in the United States for three of the past five years
How to Apply?
In order to apply for the following fellowship, the candidate will have to submit the below-mentioned materials, and in addition to that, you must submit a personal statement of research goals and how they relate to the fields of translational and regulatory science. Include in your account how your goals are aligned with one or more of the project descriptions for 2022.
To receive the application guidelines, please contact TSIFellowship@nih.govexpressing your interest in the TSIF program.
Following are the documents that need to be attached with your application form:
- An updated resume
- A copy of an unofficial academic transcript
- Three letters of reference
The fellows of the following fellowship will be trained in preclinical translational science, technology development, and regulatory research and review. By combining training in translational science and research-related regulatory review, this program will enable fellows to build awareness of regulatory requirements into the early stages of medical product development, making both the development and review processes more efficient. Fellows in this program will develop skills of value to future careers in academia, the pharmaceutical industry, and government.
The deadline to apply for the following fellowship is December 15, 2021. No applications will be acceptedpast the deadline.